Inogen | INGN - Stammkapital





Stammkapital Veränderung Datum
Abbott USD 1.74B 2.94M 2026-03
Accuray USD 100K 1000 2024-09
AngioDynamics USD 41.57M 127K 2025-09
Artivion USD 47.84M 468K 2025-12
AtriCure USD 50.64M 7K 2026-06
Baxter International USD 517M 549K 2026-06
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.11M 14K 2026-03
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 577M 3.7M 2026-03
Globus Medical USD 135.67M 611K 2026-03
Inogen USD 23K 0 2023-12
Insulet USD 69.35M 87K 2026-06
Medtronic USD 1.28B 1.38M 2025-12
Orthofix International USD 39.83M 315K 2025-12
Philips EUR 952.02M 729K 2026-03
ResMed USD 145.06M 45.78M 2026-06
Steris USD 98.07M 72K 2026-03
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.54M 1.04M 2026-06
Teleflex USD 44.26M 70K 2026-03
X T L Biopharmaceuticals USD 946.24M 64.86M 2025-12
Zimmer Biomet Holdings USD 193.4M 2.1M 2026-06